$15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"medicare fee schedule and coverage for skin cancer treatments"
You can find more data on corporate lobbying on Quiver Quantitative.
SRTS Insider Trading Activity
SRTS insiders have traded $SRTS stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:
- JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 25,000 shares for an estimated $100,750
- ERIC SACHETTA has made 2 purchases buying 9,500 shares for an estimated $38,760 and 0 sales.
- MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) has made 3 purchases buying 3,000 shares for an estimated $11,430 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SRTS Hedge Fund Activity
We have seen 13 institutional investors add shares of SRTS stock to their portfolio, and 24 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 668,880 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,100,283
- PERRITT CAPITAL MANAGEMENT INC removed 469,692 shares (-78.9%) from their portfolio in Q3 2025, for an estimated $1,474,832
- ACADIAN ASSET MANAGEMENT LLC removed 148,282 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $465,605
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 128,224 shares (+39.5%) to their portfolio in Q3 2025, for an estimated $402,623
- PACIFIC RIDGE CAPITAL PARTNERS, LLC added 125,245 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $498,475
- MEROS INVESTMENT MANAGEMENT, LP added 74,749 shares (+75.3%) to their portfolio in Q3 2025, for an estimated $234,711
- GSA CAPITAL PARTNERS LLP removed 71,696 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $225,125
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SRTS Analyst Ratings
Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
To track analyst ratings and price targets for SRTS, check out Quiver Quantitative's $SRTS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
